Q1 2014 13F Holders as of 31 Mar 2014
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
1,672,276
-
Share change
-
-366,442
-
Total reported value
-
$10,634,000
-
Price per share
-
$6.36
-
Number of holders
-
18
-
Value change
-
-$2,328,045
-
Number of buys
-
9
-
Number of sells
-
6
Institutional Holders of ADAMIS PHARMACEUTICALS CORP - COM NEW (ADMP) as of Q1 2014
As of 31 Mar 2014,
ADAMIS PHARMACEUTICALS CORP - COM NEW (ADMP) was held by
18 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,672,276 shares.
The largest 10 holders included
MARXE AUSTIN W & GREENHOUSE DAVID M, GROW Partners, LLC, BARD ASSOCIATES INC, SCOGGIN LLC, DAFNA Capital Management LLC, GRANITE POINT CAPITAL MANAGEMENT, L.P., GOLDMAN SACHS GROUP INC, SABBY MANAGEMENT, LLC, SPRINGBOK CAPITAL MANAGEMENT, LLC, and BlackRock Institutional Trust Company, N.A..
This page lists
18
institutional shareholders reporting positions in this security
for the Q1 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.